A study investigating pharmacokinetics of efavirenz in HIV infected pregnant women with or without tuberculosis

Next Previous
Trial Profile

A study investigating pharmacokinetics of efavirenz in HIV infected pregnant women with or without tuberculosis

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2015

At a glance

  • Drugs Efavirenz (Primary) ; Isoniazid; Rifampicin
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms TSHEPISO

    • Most Recent Events

    • 07 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top